Senior insider sale
Chief Financial Officer at ENTRADA THERAPEUTICS, INC. — senior position signals high conviction
$91.1K
10.64K shares
What this filing means
WENTWORTH KORY JAMES plans to sell 10.64K shares of ENTRADA THERAPEUTICS, INC. valued at approximately $91.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/21/2025ACC: 0001950047-25-009207
Officer· Chief Financial Officer
Since Oct 2021
10.64K
Shares to sell
$91.1K
Approx. market value
8.91K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/1/2025
8.91KTotal acquired8.91K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2025 | Restricted Stock Units N/A | 8.91K | — |
| Total | 8.91K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.73K
Market value
$9.4K
9/2/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.91K
Market value
$81.7K
11/21/2025
Total
Units
10.64K
Value
$91.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/2/2025 | 1.73K | $9.4K | — | Completed |
| Planned — Approximate Date | ||||
11/21/2025 | 8.91K | $81.7K | NASDAQ | Planned |
| Total | 10.64K | $91.1K | ||